RecruitingNot ApplicableNCT07110051

Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient

Comparative Study Between Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient

Sponsor

National Cancer Institute, Egypt

Enrollment

128 participants

Start Date

Jan 15, 2025

Study Type

INTERVENTIONAL

Conditions

Pediatric Cancer Abdominal Surgeries Tramadol Nalbuphine

Summary

In current study the investigators aim to compare between nalbuphine versus tramadol for post-operative pain control in abdominal surgeries in pediatric.

Eligibility

Min Age: 3 YearsMax Age: 12 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Nalbuphine and a drug called Tramadol for people with abdominal surgeries, nalbuphine, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 3 Years to 12 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGNalbuphine

this group will a single dose of nalbuphine (0.2 mg/kg) immediately after surgery to be repeated every 8 hours for the duration of the study (72 hours)

DRUGTramadol

this group will receive a single dose of tramadol (2 mg/kg) immediately after surgery to be repeated every 8 hours for the duration of the study (72 hours).